Test Price
1,500 AED✅ Home Collection Available
SCA‑14 (PRKCG Gene Mutation) Test in UAE | 1500 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid hospital‑grade cold‑chain home collection (8 AM‑11 PM) with certified VIP mobile phlebotomy.
- Clinical Guidance: Post‑test telephonic result interpretation by a DHA‑licensed clinical geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SCA‑14 (PRKCG Gene Mutation) test is a definitive genetic assay that identifies pathogenic variants in the PRKCG gene causing autosomal dominant spinocerebellar ataxia type 14, a progressive cerebellar degenerative disorder.
Methodology: PCR amplification followed by bidirectional Sanger sequencing of the PRKCG coding exons and flanking intronic regions. The assay achieves 99.9% analytic sensitivity and specificity for the target gene.
| Parameter | Our SCA‑14 PRKCG Test | Closest Alternative (WES‑Based) |
|---|---|---|
| Methodology | PCR + Sanger Sequencing (bi‑directional dye terminator) | Whole Exome Sequencing (NGS) |
| Diagnostic Precision | 99.9% analytic sensitivity & specificity for PRKCG | ~99.5%; potential incidental findings |
| Turnaround Time | 10‑12 days | 15‑21 days |
| Cost | 1500 AED | 3,500‑5,000 AED |
Physician Insight & Safety Protocols
“This PRKCG gene test is a valuable diagnostic tool for autosomal dominant spinocerebellar ataxia, but results must be interpreted alongside a thorough neurological evaluation and family history. A positive finding indicates a genetic predisposition and should prompt a discussion with a DHA‑licensed clinical geneticist before any medical decisions are made. Our team is committed to guiding you through the entire diagnostic pathway.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Advisory Notice
Do not alter or discontinue any prescribed medication without consulting your physician. Genetic results are not a substitute for ongoing clinical management and should be reviewed in conjunction with your treating doctor.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Minors (<18 years) without legal guardian consent; pregnancy without prior genetic counselling; patients with a bleeding disorder that contraindicates venipuncture.
- Emergency Red Flags: Sudden inability to stand or walk, severe vertigo, new‑onset slurred speech, choking on liquids – seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What is the SCA‑14 PRKCG gene mutation test?
This test detects pathogenic variants in the PRKCG gene that cause spinocerebellar ataxia type 14, an inherited neurological disorder.
2. How should I prepare for the PRKCG gene test?
Provide a duly filled Genomic Information Form (Form 20) and 4 mL whole blood in an EDTA tube. The sample must be refrigerated without freezing and transported under temperature‑controlled conditions.
3. How long do results for the SCA‑14 test take?
Results are typically delivered within 10 to 12 business days, inclusive of detailed Sanger sequencing analysis and clinical interpretation.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE complies with all applicable UAE data protection and health information regulations, including:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, storage, and processing of personal data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure handling of electronic health records and genetic data.
- Dubai Health Authority (DHA) regulations for diagnostic laboratories, including strict confidentiality and consent protocols.
All genetic testing is performed under the oversight of our DHA‑licensed facility (License No. 1143).
Clinical & Logistical Metadata
| Test Name | SCA-14 (PRKCG Gene Mutation) Test |
| Price (AED) | 1500 AED |
| Turnaround Time | 10-12 Business Days |
| Sample Type / Matrix | Whole Blood (EDTA), 4 mL |
| Methodology Used | PCR + Bidirectional Sanger Sequencing |
| ICD-10-CM Code | G11.2 |
| LOINC Code | 98590-0 |
| DHA Facility License & Laboratory Address | DHA License No: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians